JENBURKT PHARMACEUTICALS
Back to Balance Sheet
|
JENBURKT PHARMACEUTICALS Last 5 Year Contingent Liabilities History
[Standalone]
Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
---|---|---|---|---|---|
Contingent Liabilities | ₹16 Cr | ₹17 Cr | ₹20 Cr | ₹17 Cr | ₹17 Cr |
What is the latest Contingent Liabilities ratio of JENBURKT PHARMACEUTICALS ?
Year | Contingent Liabilities |
---|---|
Mar2025 | ₹16 Cr |
Mar2024 | ₹17 Cr |
Mar2023 | ₹20 Cr |
Mar2022 | ₹17 Cr |
Mar2021 | ₹17 Cr |
How is Contingent Liabilities of JENBURKT PHARMACEUTICALS Trending?
Years | Contingent Liabilities | % Change | |
---|---|---|---|
Mar2025 | ₹16 Cr | -0.45 | |
Mar2024 | ₹17 Cr | -15.25 | |
Mar2023 | ₹20 Cr | 17.75 | |
Mar2022 | ₹17 Cr | -0.19 | |
Mar2021 | ₹17 Cr | - |
Compare Contingent Liabilities of peers of JENBURKT PHARMACEUTICALS
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
JENBURKT PHARMACEUTICALS | ₹465.1 Cr | -5.3% | -7% | -0% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹391,368.0 Cr | 0.7% | -0.7% | -11% | Stock Analytics | |
DIVIS LABORATORIES | ₹160,631.0 Cr | NA | -1.6% | 12.1% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹123,641.0 Cr | 3.1% | -0.9% | 9.1% | Stock Analytics | |
CIPLA | ₹123,419.0 Cr | -2% | -4% | -5.9% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹109,176.0 Cr | -0.2% | 2.4% | 0% | Stock Analytics |
JENBURKT PHARMACEUTICALS Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
JENBURKT PHARMACEUTICALS | -5.3% |
-7% |
-0% |
SENSEX | -0.3% |
0.1% |
-1% |
You may also like the below Video Courses